AGP Wins 1st Position in Pharmaceutical Category at BCSR Awards 2024 — for the Second Consecutive Year!

AGP Celebrates Dual Recognition at the 8th Pakistan Pharma Summit & PESA Awards 2025

AGP Receives the 22nd Annual Environment Excellence Award 2025

AGP Wins GDEIB Awards in Nine Categories

AGP x TrashIt Sustainability Training

AGP x Cyber Security Awareness Training

AGP x Cancer Foundation Hospital: Breast Cancer Awareness Session

AGP Visits Karachi Down Syndrome Program (KDSP)

Diwali Celebration at AGP: Honoring Diversity, Culture & Togetherness

AGP Limited Secures 1st Position at BCSR Awards 2023

AGP collaborates with Childlife Foundation on Children’s Day 2023

AGP Launched Peridots – A Thanda Solution to Acidity, Gas and Indigestion

AGP secures 2nd Position at BCR Awards 2022

AGP wins Top Exporter Award at 6th PPMA Summit

AGP sponsors KDSP Carnival 2023

AGP bags big win at GDEIB Awards 2023

AGP continues partnership with IBA

AGP continues collaboration with TCF

AGP joins hands with SKMF

AGP continues partnership with ACF

AGP conducts Allergy Awareness Session At Pak Turk Maarif

Gong-Ringing Ceremony of AGP at PSX

Product List

Urgesin

Generic

Solifenacin Succinate

Therapeutic Class:

Urinary Incontinence Prd

 

Composition:

Each Urgesin tab contains 5 mg
or 10 mg of solifenacin succinate.

 

Description:

Urgesin (Solifenacin) is used to
treat contraction of overactive bladder with associated problems such as
increased urination frequency and urge incontinence.

 

Indications:

Urgesin is a muscarinic
antagonist indicated for the treatment of overactive bladder with symptoms
of urge urinary incontinence, urgency and urinary frequency.

 

Dosage:

The recommended dose of Urgesin
is 5 mg once daily. If the 5 mg dose is well tolerated, the dose may be
increased to 10 mg once daily.

 

Presentations:

  • Urgesin 5 mg tab is available in pack of 10’s.
  • Urgesin 10 mg Tab is available in pack of 10’s.